丽珠医药(01513.HK)8月26日耗资302万元回购7.26万股A股

Core Viewpoint - Lijun Pharmaceutical (01513.HK) announced a share buyback of 72,600 A-shares at a cost of 3.02 million yuan on August 26 [1] Company Summary - The company executed a buyback program, indicating a commitment to enhancing shareholder value [1] - The total expenditure for the buyback was 3.02 million yuan, reflecting the company's financial strategy [1] - The number of shares repurchased was 72,600, which may influence the stock's market performance [1]